Navigation Links
FPR Specialty Pharmacy Hires Slomski To Lead Sales And Marketing; Moves To Next Phase In Cleveland Clinic Trials
Date:1/8/2014

VICTOR, N.Y., Jan. 8, 2014 /PRNewswire/ -- FPR Specialty Pharmacy, developer of Focused Pain Relief—custom transdermal creams for pain and inflammation—today announced the appointment of Douglas B. Slomski to the position of Vice President of Sales and Marketing.  Effective immediately, Slomski will be responsible for expanding the company's presence in existing markets, as well as opening new markets and launching products. The company also announced today that the Cleveland Clinic study for the treatment of knee pain using Diclofenac Cream 8% or 1% has moved to the next phase, with participant enrollment to begin in the first quarter of 2014.

Slomski brings to FPR Specialty Pharmacy a 25-year background in marketing life-science products and extensive expertise in medical sales management. He most recently served on the management team at ECA Medical Instruments, where he helped with the global unveiling of a line of surgical kitting products and oversaw a five-year branding and implementation program.  Known for his solutions-based approach, Slomski is a global expert at growing revenue and market share through end-to-end product management and targeted sales strategies. He is also credited with over 12 patents in medical devices, packaging and sterilization processing equipment.

"FPR Specialty Pharmacy has exciting and aggressive plans to move the company forward in 2014. Doug Slomski is a top talent in the industry and his knowledge will further strengthen our management team and our position to achieve our goals," said Billy Rue, CEO of FPR Specialty Pharmacy.

As part of its expansion efforts, FPR Specialty Pharmacy is engaging in the Cleveland Clinic study to measure the effectiveness of Diclofenac creams in treating knee pain.  This research will provide valuable insights for treating pain and inflammation in the knee.  "This is a hallmark study for our industry and we greatly value partnering with the Cleveland Clinic on this project," said Rue. 

ABOUT FPR SPECIALTY PHARMACY
FPR Specialty Pharmacy is an advanced traditional compounding pharmacy specializing in solutions for relief of pain and inflammation.  The company's leading product, Focused Pain Relief, is a custom compounded, prescription-based transdermal cream. FPR Specialty Pharmacy is located in Victor, New York.  Learn more at: www.focusedpainrelief.com or follow FPR Specialty Pharmacy on LinkedIn.


'/>"/>
SOURCE FPR Specialty Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Numotion Acquires Specialty Wheelchairs, LLC
2. Endo to Acquire Specialty Pharmaceutical Company NuPathe
3. New Physicians Survey: Most Drugstores Lack the Expertise and Capability to Provide Specialty Medications
4. Giant Eagle Expands Specialty Pharmacy with Acquisition, Bringing Treatment Expertise to Customers with Hepatitis C and Organ Transplant Conditions
5. Tampa Pharmacist Receives Specialty Pharmacy Certification Credential from SPCB
6. Centene Specialty Pharma Subsidiary Receives Full URAC Accreditation
7. CVS Caremark to Purchase Coram Infusion Business from Apria Healthcare, Expanding Specialty Pharmacy Offering
8. Student Residency Program Planned by the National Association of Specialty Pharmacy (NASP)
9. Global Markets For Specialty Surgical Wound Care Products In 2013: Surgical Sealants, Glues, Absorbable Hemostats, And Adhesion Prevention Products
10. Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials
11. Pan Foundation Convenes Dialogue Series On Issues Surrounding Access To Specialty Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and ... ... ... ... ...
(Date:5/3/2016)...   BIOTRONIK will be exhibiting and initiating ... implant at the Heart Rhythm Society,s 37 th ... Francisco . "Physicians and hospitals ... patient care and satisfaction possible. Part of that process ... tomorrow," said Marlou Janssen , President, BIOTRONIK, Inc. ...
(Date:5/3/2016)... , May 3, 2016 ... INTP), a clinical-stage biopharmaceutical company, today announced the appointment ... and Regulatory Affairs. "Ms. Strauss-Levy has 15 ... and has established an outstanding track record, having supported ... and regulatory approval processes in the United ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... 03, 2016 , ... With the opioid epidemic now at the forefront, attention ... use. Alcohol and its misuse causes long-term consequences for all aspects of society, ... in those 65 years and older. In addition, there is the long term ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... DNA or RNA from a random library of sequences depending on their attraction ... or diagnostic agents. SELEX selection is commonly performed using filters, panning, or affinity ...
(Date:5/3/2016)... ... 2016 , ... Sandbox, one of the nation’s leading independent ... newly created position of executive vice president, chief creative officer.     , In his ... and LA offices. He reports to Nancy Finigan, president of those offices. , ...
(Date:5/3/2016)... ... , ... Elizabeth Murray has always loved walking one to two miles a ... shoulder and one on her arm. But she got to the point where she ... prolapse. , The valves of the heart wouldn’t close properly resulting in mitral regurgitation, ...
(Date:5/3/2016)... ... 03, 2016 , ... Excessive panting in the car or cowering when new ... often think anxiety only manifests itself as trembling or ‘tail between the legs,’ but ... that be done about it,” says Dr. Jim Lowe, technical services veterinarian for Tomlyn ...
Breaking Medicine News(10 mins):